← Leaderboards
Bridgette L. Jones
Children'S Mercy Hosp (Kansas City, Mo)
$4,441,214
Attributed
$6,186,933
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2011–25$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,186,933 · 4
By mechanism
R01$2,494,169 · 1
UG1$2,173,638 · 1
K12$878,533 · 1
K23$640,593 · 1
Top collaborators
- Ann M Davis6 shared
- Daniel K Benjamin4 shared
- Daniel Gonzalez4 shared
- Adriana H Tremoulet4 shared
Others in their field
Top investigators on “Childhood”
- Gregory H Reaman · National Childhood Cancer Foundation$268,060,146
- Barbara Driver · Westat, Inc.$206,410,885
- Sharon A Nachman · Johns Hopkins University$191,166,598
- Peter C Adamson · National Childhood Cancer Foundation$190,988,407
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$187,267,729
- James E. Gern · University Of Wisconsin-Madison$149,875,125
Research focus
ChildhoodChildSuccessResearch PersonnelPharmaceutical PreparationsTrainingFutureSkillsEffectivenessMentorsExtrinsic AsthmaIontophoresisExposure ToTreatment ResponseHistamineAsthmaMonitorLasersAntihistaminesPediatric PatientsGenesGenetic PolymorphismFunctional DisorderGenerations
Grant awards (22)
Sunflower Pediatric Clinical Trials (SPeCTr 3.0)$410,437
UG1 · FY2025 · OD
National Career Development Program for Researchers in Pediatric Clinical Pharmacology$292,194
K12 · FY2025 · HD
SPeCTRE 2.0: The Sunflower Pediatric Clinical Trials Research Extension$398,369
UG1 · FY2024 · OD
National Career Development Program for Researchers in Pediatric Clinical Pharmacology$292,194
K12 · FY2024 · HD
A Histamine Pharmacodynamic Biomarker to Guide Treatment in Pediatric Asthma$283,465
R01 · FY2024 · HD · contact PI
A Histamine Pharmacodynamic Biomarker to Guide Treatment in Pediatric Asthma$511,735
R01 · FY2023 · HD · contact PI
SPeCTRE 2.0: The Sunflower Pediatric Clinical Trials Research Extension$402,647
UG1 · FY2023 · OD
National Career Development Program for Researchers in Pediatric Clinical Pharmacology$294,144
K12 · FY2023 · HD
A Histamine Pharmacodynamic Biomarker to Guide Treatment in Pediatric Asthma$71,316
R01 · FY2023 · HD · contact PI
A Histamine Pharmacodynamic Biomarker to Guide Treatment in Pediatric Asthma$49,296
R01 · FY2023 · HD · contact PI
National Career Development Program for Researchers in Pediatric Clinical Pharmacology$1
K12 · FY2023 · HD
A Histamine Pharmacodynamic Biomarker to Guide Treatment in Pediatric Asthma$508,269
R01 · FY2022 · HD · contact PI
SPeCTRE 2.0: The Sunflower Pediatric Clinical Trials Research Extension$406,311
UG1 · FY2022 · OD
SPeCTRE 2.0: The Sunflower Pediatric Clinical Trials Research Extension$142,943
UG1 · FY2022 · OD
A Histamine Pharmacodynamic Biomarker to Guide Treatment in Pediatric Asthma$520,693
R01 · FY2021 · HD · contact PI
SPeCTRE 2.0: The Sunflower Pediatric Clinical Trials Research Extension$412,931
UG1 · FY2021 · OD
A Histamine Pharmacodynamic Biomarker to Guide Treatment in Pediatric Asthma$549,395
R01 · FY2020 · HD · contact PI
Characterization of the Role of Histamine in Children with Asthma$126,735
K23 · FY2015 · HL · contact PI
Characterization of the Role of Histamine in Children with Asthma$128,625
K23 · FY2014 · HL · contact PI
Characterization of the Role of Histamine in Children with Asthma$128,301
K23 · FY2013 · HL · contact PI
Characterization of the Role of Histamine in Children with Asthma$128,466
K23 · FY2012 · HL · contact PI
Characterization of the Role of Histamine in Children with Asthma$128,466
K23 · FY2011 · HL · contact PI